treatment arm

treatment arm

Active arm Clinical trials In a placebo- controlled trial, the arm that receives a particular therapy
References in periodicals archive ?
In the largest study, conducted over the course of nine weeks with more than 1,100 adults with chronic insomnia and depression, the treatment arm received the investigational PDT, and the comparator arm received an attention-matched digital placebo along with usual care.
The tanezumab 5 mg treatment arm met two of the three co-primary efficacy endpoints, demonstrating a statistically significant improvement in pain and physical function compared to NSAIDs at the 16-week analysis, while patients overall assessment of their OA was not statistically different than NSAIDs.
In the DARZALEX-Rd treatment arm, patients received DARZALEX 16 milligrams per kilogram (mg/kg) IV weekly.
Few patients, roughly 20% in each treatment arm, had achieved the primary endpoint, a complete cure (0% nail involvement and negative KOH stain and culture) at the end of active treatment, Dr.
The baseline characteristics for participants in each treatment arm were similar, except that participants in the vaginal estriol group were less symptomatic at baseline.
The incidence rate of treatment-related adverse events was 26.5% for the placebo arm, 53.4% for the 10 mg/kg monthly treatment arm and 47.2% for the 10 mg/kg biweekly treatment arm.
The study's primary endpoint was the percentage of patients in each treatment arm who had a "successful" outcome, defined as at least a 50% improvement in their gastroesophageal reflux health-related quality of life score (J Gastrointest Surg.
Second, there was an important baseline difference between the treatment arms in day of illness at study enrollment: Patients presenting later in their illness were more likely to be allocated to the hypertonic saline treatment arm in 6 of the 18 studies assessed, most of which were small positive studies.
About half of the patients enrolled in the trial underwent microbiologic assessment of their infecting pathogen, and about 40% of cases in each treatment arm had infections caused by S.
16 November 2011 - South Korean civil engineering group GS Engineering & Construction Corp (SEO:006360) on Wednesday announced the acquisition of Inima SAU, the environmental and water treatment arm of Spanish builder Obrascon Huarte Lain SA (MCE:OHL), for EUR231m (USD311m).
A minimum of 35 patients per treatment arm (70 in total) were required to have an 80% power of detecting a true difference in primary outcome with [alpha] of 0.05.
The study also found a statistically significant reduction in the risk of extrapulmonary tuberculosis in the early treatment arm: 17 cases occurred in the deferred treatment arm, compared with 3 cases in the early treatment arm (p=0.0013).

Full browser ?